SCHEMBL11005542

SCHEMBL11005542

CC1(C)C=C(C(=O)O)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 8/20 0.35
▸ SRD5A1 P18405 3/20 0.35
▸ TSHR P16473 2/20 0.33
▸ FFAR3 O14843 1/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRR1 P24046 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ GABRA4 P48169 1/20 0.33
▸ GABRE P78334 1/20 0.33
▸ GABRA6 Q16445 1/20 0.33
▸ GABRG1 Q8N1C3 1/20 0.33
▸ GABRG3 Q99928 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6641316 0.87 OAT (0.37) SRD5A2SRD5A1TSHRFFAR3GABRP
SCHEMBL28201395 0.84 — —
SCHEMBL10940131 0.78 — —
SCHEMBL24731262 0.73 GABRP (0.33) SRD5A2SRD5A1TSHRGABRPGABRD
SCHEMBL11372909 0.71 ALDH1A1 (0.31) —
SCHEMBL27325175 0.71 OAT (0.35) SRD5A2SRD5A1FFAR3OAT
SCHEMBL6862905 0.70 TSHR (0.39) SRD5A2SRD5A1TSHRFFAR3GABRP
SCHEMBL442745 0.70 ALDH1A1 (0.33) —
SCHEMBL2410833 0.68 SRD5A2 (0.33) SRD5A2SRD5A1TSHRFFAR3GABRP
SCHEMBL27647018 0.68 ALDH1A1 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4496743-A 1-[(Acylthiocycloalkyl)carbonyl]-L-proline derivatives GRUPPO LEPETIT S.P.A. (IT) 1985-01-29 — — US disclosed
US-4385062-A 1-[(-2-Mercaptocycloalkyl)carbonyl]-L-proline derivatives, the process for their manufacture, the intermediates for their synthesis and their use as anti-hypertensive agents GRUPPO LEPETIT S.P.A. (IT) 1983-05-24 — — US disclosed
Send feedback